Physician profile
Michael Dietz
NPI 1326199829
$1,250.48
in general payments reported to CMS, 2019-2025
18 companies · $91.00 in 2025
The $91.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $133 · 2021: $43.42 · 2022: $20.47 · 2023: $348 · 2024: $199 · 2025: $91.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $214.88 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $179.69 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $140.35 | 2019 | |
| Idorsia Pharmaceuticals US INC | $100.46 | 2023 | Quviviq |
| Pfizer INC. | $95.82 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $83.59 | 2020-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Astellas Pharma US INC | $72.69 | 2019-2020 | |
| Novo Nordisk INC | $58.30 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.71 | 2019 | |
| Dexcom, INC. | $52.49 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $41.06 | 2019 | |
| Glaxosmithkline, LLC. | $30.08 | 2020 | |
| Lilly USA, LLC | $27.30 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $23.85 | 2019-2020 | |
| Abbvie INC. | $22.51 | 2023 | Ubrelvy, Qulipta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.62 | 2020 | |
| Cranial Technologies, INC | $16.83 | 2019 | |
| Inspire Medical Systems, INC. | $16.25 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dietz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.